Back to directory
InoKare Therapeutics

InoKare Therapeutics

biotechChapel Hillseed
inokaretherapeutics.com

Small-molecule inhibitors targeting obesity and metabolic disorders

At a glance

  • HQ: Chapel Hill
  • Sector: Biotech
  • Stage: Seed
  • Last round: Seed

This is the free preview.

The full profile is for members: founders, funding history, investor connections, and recent signals. Accounts are free; I review every request, usually within 48 hours.

InoKare Therapeutics · Triangle Startups